Sastasundar Vent Peer Comparison
NSE: SASTASUNDR | BSE: 533259
₹304.90
As on 31-Aug-2026 12:47IST
Market cap
₹945 Cr
Revenue (TTM)
₹1,468 Cr
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
945 | 39,594 | 32,113 | 32,042 | 15,000 |
Revenue (₹ Cr) |
1,468 | 4,683 | 2,891 | 4,213 | 857 |
Net Profit (₹ Cr) |
-26.05 | 552.34 | 546.30 | 190.80 | 187.49 |
Net Margin (%) |
-1.72 | 11.55 | 18.23 | 4.49 | 21.32 |
RoE (%) |
-2.93 | 14.93 | 23.03 | 9.45 | 20.58 |
Price to Earnings |
-- | 71.19 | 59.26 | 156.84 | 80.00 |
Price-To-Book |
1.47 | 9.63 | 12.29 | 8.47 | 14.89 |
Income Statement (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Operating Income
|
1,467.69 | 4,683.37 | 2,890.80 | 4,212.50 | 857.13 |
|
Other Income
|
45.72 | 100.41 | 105.10 | 35.50 | 22.28 |
|
Total Income
|
1,170.80 | 3,797.15 | 2,554.83 | 3,067.00 | 699.71 |
|
Interest Expense
|
1.29 | 92.01 | 24.40 | 253.30 | 36.75 |
|
PBT & Exceptional Items
|
-24.38 | 740.75 | 746.80 | 284.40 | 251.42 |
|
Operating Expenses
|
1,534.24 | 3,704.62 | 2,053.10 | 3,379.70 | 495.19 |
|
Exceptional Income/Expenses
|
-1.13 | -20.61 | -30.10 | -11.20 | 0.00 |
|
Profit before Tax
|
-30.57 | 720.14 | 716.70 | 273.20 | 251.42 |
|
Taxes
|
-4.52 | 167.80 | 170.40 | 82.40 | 63.93 |
|
Profit after Tax
|
-26.05 | 552.34 | 546.30 | 190.80 | 187.49 |
|
Minority Interest
|
5.86 | 3.84 | -4.40 | 9.90 | 0.00 |
|
Share of Associate
|
0.00 | 0.00 | 0.00 | 3.60 | 0.00 |
|
Consolidated Profit
|
-20.20 | 556.18 | 541.90 | 204.30 | 187.49 |
Liabilities (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
640.89 | 3,961.57 | 2,508.20 | 2,247.40 | 957.15 |
|
Minority Interest
|
5.86 | 3.84 | -4.40 | 9.90 | 0.00 |
|
Non-Current Liabilities
|
28.75 | 1,293.60 | 154.00 | 3,961.30 | 426.03 |
|
Current Liabilities
|
141.74 | 627.13 | 450.70 | 1,238.90 | 123.87 |
|
Total Liabilities
|
970.40 | 4,766.23 | 2,713.41 | 5,689.20 | 1,273.62 |
Assets (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
131.55 | 3,128.95 | 1,176.30 | 5,416.90 | 737.24 |
|
Current Assets
|
590.70 | 1,674.92 | 1,566.60 | 937.40 | 321.90 |
|
Total Assets
|
970.40 | 4,766.23 | 2,713.41 | 5,689.20 | 1,273.62 |
|
Contingent Liabilities
|
3.53 | 88.77 | 10.59 | 83.80 | 0.13 |
Cashflow (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-17.31 | 623.76 | 568.89 | 581.80 | 224.47 |
|
Cash Flow from Investing Activities
|
-1.13 | -720.94 | -303.16 | -1,116.20 | -181.88 |
|
Cash from Financing Activities
|
-0.44 | -97.23 | -334.03 | 543.10 | -52.05 |
|
Net Cash Inflow / Outflow
|
-18.89 | -194.41 | -68.31 | 8.70 | -9.45 |
Ratios
Profitability Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-28.40 | 20.50 | 31.53 | 19.02 | 30.20 |
|
ROE (%)
|
-2.93 | 14.93 | 23.03 | 9.45 | 20.58 |
|
ROA (%)
|
-2.73 | 10.35 | 18.64 | 2.83 | 13.49 |
|
EBIT Margin (%)
|
-5.03 | 15.64 | 23.04 | 11.92 | 31.02 |
|
Net Margin (%)
|
-1.72 | 11.55 | 18.23 | 4.49 | 21.32 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
28.85 | 21.27 | 14.29 | 30.90 | 20.18 |
|
EBIT Growth (%)
|
-39.50 | 0.94 | 15.64 | -16.88 | 26.22 |
|
Net Profit Growth (%)
|
82.23 | 3.43 | 5.38 | -52.81 | 24.27 |
|
EPS Growth (%)
|
-183.72 | 2.70 | -30.51 | -42.60 | 23.44 |
|
Book Value Growth (%)
|
-11.55 | 16.71 | 17.68 | 16.93 | 19.36 |
Valuation Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-48.55 | 69.04 | 45.29 | 145.70 | 79.61 |
|
Price / Book Value
|
1.46 | 9.62 | 12.40 | 8.54 | 14.85 |
|
Dividend Yield (%)
|
0.00 | 0.03 | 1.06 | 0.00 | 0.14 |
|
EV/EBITDA
|
-9.26 | 39.89 | 37.09 | 42.61 | 40.54 |
|
Market Cap (₹ Cr)
|
771.89 | 32,181.74 | 20,714.85 | 25,571.93 | 10,333.01 |
Solvency Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 0.00 | 1.19 | 0.00 |
|
Short term debt to equity ratio
|
0.03 | -- | -- | 0.06 | -- |
|
Current Ratio
|
4.17 | 2.67 | 3.48 | 0.76 | 2.60 |
|
Quick Ratio
|
4.17 | 2.54 | 3.38 | 0.68 | 2.56 |
|
Interest Coverage
|
-22.70 | 8.83 | 30.37 | 2.08 | 7.84 |